Safety of Direct Oral Anticoagulants versus Warfarin in Patients with Chronic Liver Disease and Atrial Fibrillation

ConclusionNo significant differences in bleeding rates were noted in patients treated with warfarin and DOAC agents. Further studies evaluating DOAC agents are needed to better understand the optimal anticoagulation strategy in setting of CLD.This article is protected by copyright. All rights reserved.

Source: European Journal of Haematology - February 1, 2018 Category: Hematology Authors: Pavel Goriacko, Keith T. Veltri Tags: Original Article Source Type: research